HHS' OIG report highlights the need for increased oversight of remote patient monitoring in Medicare, citing concerns about appropriate use, billing, and potential fraud.
The FDA issued warning letters to two Chinese nonclinical testing labs, citing laboratory oversight failures and animal care violations, raising concerns about data quality and...
